- Home
- ITOS vs DH Comparison
ITOS vs DH Comparison
Compare ITOS & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- DH
- Stock Information
- Founded
- ITOS 2011
- DH 2011
- Country
- ITOS United States
- DH United States
- Employees
- ITOS N/A
- DH N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- DH Computer Software: Prepackaged Software
- Sector
- ITOS Health Care
- DH Technology
- Exchange
- ITOS Nasdaq
- DH Nasdaq
- Market Cap
- ITOS 270.7M
- DH 280.0M
- IPO Year
- ITOS 2020
- DH 2021
- Fundamental
- Price
- ITOS $6.51
- DH $2.53
- Analyst Decision
- ITOS Strong Buy
- DH Hold
- Analyst Count
- ITOS 3
- DH 11
- Target Price
- ITOS $26.00
- DH $5.35
- AVG Volume (30 Days)
- ITOS 413.2K
- DH 1.3M
- Earning Date
- ITOS 05-09-2025
- DH 05-06-2025
- Dividend Yield
- ITOS N/A
- DH N/A
- EPS Growth
- ITOS N/A
- DH N/A
- EPS
- ITOS N/A
- DH N/A
- Revenue
- ITOS $35,000,000.00
- DH $252,202,000.00
- Revenue This Year
- ITOS N/A
- DH N/A
- Revenue Next Year
- ITOS $31.74
- DH $2.81
- P/E Ratio
- ITOS N/A
- DH N/A
- Revenue Growth
- ITOS 177.89
- DH 0.31
- 52 Week Low
- ITOS $4.80
- DH $2.15
- 52 Week High
- ITOS $18.75
- DH $7.57
- Technical
- Relative Strength Index (RSI)
- ITOS 55.62
- DH 36.31
- Support Level
- ITOS $4.80
- DH $2.15
- Resistance Level
- ITOS $5.55
- DH $2.63
- Average True Range (ATR)
- ITOS 0.43
- DH 0.18
- MACD
- ITOS 0.13
- DH 0.04
- Stochastic Oscillator
- ITOS 97.16
- DH 45.24
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About DH Definitive Healthcare Corp.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.